Bio Digital Digital Innovation
Suvoda Expands Unified Clinical Trial Platform With AI-Powered Capabilities
- Suvoda, a global clinical trial technology company, announced a new release of important advancements since unifying the market-leading Suvoda...
October 02, 2026 | News
CAS and Novartis Partner to Build AI-Ready Reaction Data Platform for Drug Discovery
Researchers will gain an integrated synthetic data foundation and an advanced custom search platform to support reaction data discovery and analysis ...
October 01, 2026 | News
Accuray, Samsung NeuroLogica Partner to Advance Volumetric Imaging for CyberKnife
Accuray Incorporated announced that it had entered into agreements with Samsung HME America, Inc., dba NeuroLogica Corp. ("Samsung NeuroLogica") to pursue ...
September 29, 2026 | News
HORIEN Secures Thai FDA Class 4 Approvals for Three Regenerative Medical Devices
Market-entry initiative targets qualified Thai distributors across dental, surgical, wound-care, and regenerative medicine channels, while solidifying glob...
September 09, 2026 | News
SIBIONICS Showcases AI-Powered GS3 Glucose Monitoring, Advances Integrated Diabetes Care at Melbourne Congress
SIBIONICS showcased its sensor innovation and AI-powered glucose monitoring at the joint IDF-WPR, ADC and Metabolic Diseases 2026 congress, held in Melbour...
September 01, 2026 | News
Intuitive to Establish 316,000-Sq-Ft Robotic Surgery Manufacturing Facility in Penang
New 316,000-square-foot facility is expected to begin operations in 2028 and create 1,200 highly skilled jobs by 2032 Intuitive (NASDAQ: ISRG), a global t...
August 19, 2026 | News
Why Korea, Why Now? Korean Biotech Looks to Taiwan as Asia’s Next Partnership Frontier
Korea’s biotechnology industry is entering a new phase of global ambition. Having established significant capabilities across biopharmaceutical manuf...
July 20, 2026 | News
Piramal Pharma Solutions Expands US ADC Manufacturing Capability With New Payload Linker Suite In Michigan
The Riverview facility provides comprehensive services for active pharmaceutical ingredients (APIs) and high potency APIs (HPAPIs), including specialized...
May 15, 2026 | News
HanchorBio, Inc. Partners With Bloomberg To Strengthen Data Driven Biopharma Strategy
Expanding HanchorBio's data-enabled approach from molecule design to portfolio and market insight -- HanchorBio, Inc. (TPEx: 7827), a global clinical-stag...
April 27, 2026 | News
Datasea Delivers AI Multimodal Projects Worth RMB 6.9 Million To Accelerate High Margin Shift
Completed Projects Further Support the Company's Transition Toward High-Margin, Solution-Driven Revenue and Strengthen Customer Stickiness Across AI Multim...
April 22, 2026 | News
Clarity Pharmaceuticals Signs Copper 64 Supply Agreement With Theragenics To Advance Radiopharmaceutical Commercialisation
Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation pr...
March 27, 2026 | News
Insilico Medicine Launches PandaClaw To Advance AI Driven Drug Discovery And Target Identification
Insilico Medicine ("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, announced the launch of ...
March 25, 2026 | News
Belief BioMed And Grand Life Sciences Forge Exclusive Pact To Advance Hemophilia A Gene Therapy
Belief BioMed ("BBM") and Grand Life Sciences Group Co., Ltd. ("Grand Life Sciences") today announced an exclusive collaboration agreement. Under the agree...
March 24, 2026 | News
Epigenica Expands Into Japan Through PrimeTech Partnership To Advance Epigenetic Research
Epigenica AB, a company commercializing advanced tools for epigenetic analysis, announced a distribution agreement with PrimeTech Co., Ltd., a leadin...
March 20, 2026 | News
Most Read
- Can APAC Biomanufacturing Decarbonise Without Pricing Itself Out?
- The Algorithm on the GMP Floor: AI Promises a Smarter Plant. Regulators Demand the Audit Trail.
- APAC's Peptide-Capacity Gamble
- After the Rush: APAC's mRNA and Vaccine Capacity Hangover
- The Biosimilar Race: Factory to the World — or Stuck in the Copycat Economy?
- The Vein-to-Vein Problem: Can APAC's Cold Chain Carry Advanced Therapies?
- Vectors, Plasmids and the CGT Trap: APAC's Cell and Gene Therapy Ambitions Face an Upstream Bottleneck
- Can APAC Build Radioligand Therapy Before the Atoms Decay?
- The Great Biopharma Reset: 50 Developments That Changed Everything in H1 2026
- Beyond the Trial: Can Real-World Evidence Earn Regulatory Trust in APAC?
- Beyond the Obvious Giant: Where APAC's Clinical Trials Go Next
- The Frontier That Won’t Quite Arrive
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
